DDrare: Database of Drug Development for Rare Diseases

Blood tests (DrugBank: -)

2 diseases

ID	Disease name (Link within this page)	Number of trials
46	Malignant rheumatoid arthritis	1
263	Cerebrotendinous xanthomatosis	1

46. Malignant rheumatoid arthritis [ 4,183 clinical trials, 2,538 drugs, (DrugBank: 401 drugs), 183 drug target genes, 219 drug target pathways]

Searched query = "Malignant rheumatoid arthritis", "Rheumatoid arthritis", "Rheumatoid arthritis with vasculitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 4,183 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04584541 (ClinicalTrials.gov)	June 11, 2020	10/6/2020	SarS-Cov-2 Viral Infection (COVID-19) in Patients With Chronic Inflammatory Rheumatism	Study of the Viral Load and Humoral and Cellular B and T Responses in Patients With Rheumatoid Arthritis and Spondyloarthritis Under Immunosuppressive Treatments	Spondyloarthritis;Rheumatoid Arthritis;Covid19	Biological: blood tests;Biological: Nasopharyngeal swabs;Biological: Stools	Assistance Publique - Hôpitaux de Paris	NULL	Recruiting	18 Years	N/A	All	150	N/A	France

263. Cerebrotendinous xanthomatosis [ 5 clinical trials, 10 drugs, (DrugBank: 2 drugs), 2 drug target genes, 4 drug target pathways]

Searched query = "Cerebrotendinous xanthomatosis", "27-hydroxylase deficiency", "CYP27 deficiency"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 5 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01613898 (ClinicalTrials.gov)	August 2010	22/5/2012	Evaluation of Carotid IMT and Atherogenic Risk Factors in Patients With Cerebrotendinous Xanthomatosis	Evaluation of Carotid IMT and Atherogenic Risk Factors in Patients With Cerebrotendinous Xanthomatosis	Cerebrotendinous Xanthomatosis (CTX)	Biological: Blood tests	Sheba Medical Center	NULL	Recruiting	10 Years	N/A	Both	17	N/A	Israel